193 related articles for article (PubMed ID: 11013359)
1. Expression of connective tissue growth factor in cartilaginous tumors.
Shakunaga T; Ozaki T; Ohara N; Asaumi K; Doi T; Nishida K; Kawai A; Nakanishi T; Takigawa M; Inoue H
Cancer; 2000 Oct; 89(7):1466-73. PubMed ID: 11013359
[TBL] [Abstract][Full Text] [Related]
2. NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia.
Yu C; Le AT; Yeger H; Perbal B; Alman BA
J Pathol; 2003 Dec; 201(4):609-15. PubMed ID: 14648665
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
[TBL] [Abstract][Full Text] [Related]
4. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor in drug-induced gingival overgrowth.
Uzel MI; Kantarci A; Hong HH; Uygur C; Sheff MC; Firatli E; Trackman PC
J Periodontol; 2001 Jul; 72(7):921-31. PubMed ID: 11495141
[TBL] [Abstract][Full Text] [Related]
6. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
[TBL] [Abstract][Full Text] [Related]
7. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.
Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J
Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP receptor in cartilaginous tumours: a marker for malignancy?
Kunisada T; Moseley JM; Slavin JL; Martin TJ; Choong PF
Pathology; 2002 Apr; 34(2):133-7. PubMed ID: 12009094
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells.
Shimo T; Nakanishi T; Kimura Y; Nishida T; Ishizeki K; Matsumura T; Takigawa M
J Biochem; 1998 Jul; 124(1):130-40. PubMed ID: 9644255
[TBL] [Abstract][Full Text] [Related]
10. Expression of insulin-like growth factor II mRNA binding protein 3 (IMP3) in enchondroma and chondrosarcoma.
Shooshtarizadeh T; Nazeri A; Zare-Mirzaie A; Movahedinia S
Pathol Res Pract; 2016 Apr; 212(4):335-9. PubMed ID: 26948096
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor-alpha receptor expression supports the growth of conventional chondrosarcoma and is associated with adverse outcome.
Sulzbacher I; Birner P; Trieb K; Mühlbauer M; Lang S; Chott A
Am J Surg Pathol; 2001 Dec; 25(12):1520-7. PubMed ID: 11717542
[TBL] [Abstract][Full Text] [Related]
12. Vascular pattern in enchondroma and chondrosarcoma: clinical and immunohistologic study.
Cintra FF; Etchebehere M; Gonçalves JC; Cassone AE; Amstalden EM
Appl Immunohistochem Mol Morphol; 2014 Sep; 22(8):600-5. PubMed ID: 24897071
[TBL] [Abstract][Full Text] [Related]
13. Expression of leukemia inhibitory factor by cartilage-forming tumors of bone: an immunohistochemical study.
Gouin F; Moreau A; Couillaud S; Guicheux J; Passuti N; Godard A; Heymann D
J Orthop Res; 1999 Mar; 17(2):301-5. PubMed ID: 10221849
[TBL] [Abstract][Full Text] [Related]
14. Genomic Profiling of Low-grade Intramedullary Cartilage Tumors Can Distinguish Enchondroma From Chondrosarcoma.
Joseph NM; McGill KC; Horvai AE
Am J Surg Pathol; 2021 Jun; 45(6):812-819. PubMed ID: 33239505
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein 72 expression in chondrosarcoma correlates with differentiation.
Trieb K; Kohlbeck R; Lang S; Klinger H; Blahovec H; Kotz R
J Cancer Res Clin Oncol; 2000 Nov; 126(11):667-70. PubMed ID: 11079732
[TBL] [Abstract][Full Text] [Related]
16. Expression of hypoxia-inducible factor-1alpha and its relationship to tumour angiogenesis and cell proliferation in cartilage tumours.
Kubo T; Sugita T; Shimose S; Matsuo T; Arihiro K; Ochi M
J Bone Joint Surg Br; 2008 Mar; 90(3):364-70. PubMed ID: 18310762
[TBL] [Abstract][Full Text] [Related]
17. Localization of connective tissue growth factor in human uterine tissues.
Uzumcu M; Homsi MF; Ball DK; Coskun S; Jaroudi K; Hollanders JM; Brigstock DR
Mol Hum Reprod; 2000 Dec; 6(12):1093-8. PubMed ID: 11101692
[TBL] [Abstract][Full Text] [Related]
18. Gadd45β expression in chondrosarcoma: a pilot study for diagnostic and biological implications in histological grading.
Zenmyo M; Tanimoto A; Sakakima H; Yokouchi M; Nagano S; Yamamoto T; Ishido Y; Komiya S; Ijiri K
Diagn Pathol; 2010 Oct; 5():69. PubMed ID: 20942912
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in cartilage tumors.
Kouvaras E; Christoni Z; Siasios I; Malizos K; Koukoulis GK; Ioannou M
Biotech Histochem; 2019 May; 94(4):283-289. PubMed ID: 30605014
[TBL] [Abstract][Full Text] [Related]
20. In malignant cartilagenous tumors, immunohistochemical expression of procollagen PC1CP peptide is higher and that of PC2CP lower than in benign cartilaginous lesions.
Delaunay-Lemarie C; Vincourt JB; Marie B; Battaglia-Hsu SF; Etienne S; Sirveaux F; Nguyen Thi PL; Magdalou J; Vignaud JM; Gauchotte G
Virchows Arch; 2015 Sep; 467(3):329-37. PubMed ID: 26100916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]